Health
Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo – News-Medical.Net
A recent study by researchers at the University of North Carolina at Chapel Hill and The Rockefeller University and published on the preprint server bioRxiv in September 2020 shows that a combination of neutralizing antibodies with intact Fc effector function…
The current COVID-19 pandemic has stimulated intensive research into the pathogenesis of the disease, especially since, in the most critical cases, hyper-inflammation secondary to immune activation appears to play a crucial role.
A recent study by researchers at the University of North Carolina at Chapel Hill and The Rockefeller University and published on the preprint server bioRxiv* in September 2020 shows that a combination of neutralizing antibodies with intact Fc effector function can effe…
